Condition: Contouring · Segmentation · Radiation Therapy · Sponsor: Royal North Shore Hospital
LOCATOR is a multicentre phase II randomised clinical trial that is looking at the process of contouring in radiation treatment for breast cancer patients. This study looks at whether contouring aided by artificial intelligence (AI) is comparable in quality to that of contouring done completely manually by a radiation oncologist. We are also looking at whether AI assisted contouring saves radiation oncologists time when compared to fully manual contouring. LOCATOR uses the LOCATOR software which is an in-house software developed locally and trained on local data.
This description comes directly from the study's public registry record.
Joseph Chan, BSc MBBS PhD FRANZCR · 94631300 · joseph.chan@health.nsw.gov.au
Heidi Tsang · 94631300 · heidi.tsang@health.nsw.gov.au
Always discuss trial participation with your own doctor first.
| Western Cancer Centre Dubbo | Dubbo, New South Wales, Australia | Recruiting |
| Central West Cancer Centre | Orange, New South Wales, Australia | Recruiting |
| Department of Radiation Oncology, Royal North Shore Hospital | St Leonards, New South Wales, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06546592